SHARE
COPY LINK

COVID-19 VACCINES

EU approves new dual-strain Covid vaccines in time for autumn booster campaigns

The European Medicines Agency has approved two new Covid vaccines that are designed to protect against both the original strain of the virus and the new Omicron variants.

EU approves new dual-strain Covid vaccines in time for autumn booster campaigns
Photo by Pascal POCHARD-CASABIANCA / AFP

Both Pfizer and Moderna had submitted applications for their dual-strain vaccines to the European Medicines Agency (EMA) in mid-July, with the agency announcing on Thursday that both had been approved.

The vaccines target both the Omicron variant and the original strain of Covid, but do not specifically target the Omicron BA.4 and BA.5 sub-variants that have emerged as the global dominant strains in recent months.

The EMA approval comes after the US approved both vaccines on Wednesday, while the UK approved the Moderna dual-strain vaccine in mid-August.

Within the EU, countries have the choice of accepting the EMA recommendation straight out, or asking their own domestic health regulator to give its approval.

The dual-strain vaccines are widely expected to be used in Covid booster shot campaigns this autumn, which many countries plan to combine with the annual flu vaccination drive. 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

HEALTH

Reader Question: Can I get a third Covid booster shot in France?

As France launches its autumn vaccine campaign, almost half of those eligible for the second booster jab in France have already received it. This has left some wondering whether they could qualify for a third booster, using the new dual-strain vaccines.

Reader Question: Can I get a third Covid booster shot in France?

Question: I’m in my 70s and I had my second booster back in the summer but now I see that the new dual-strain vaccines are available – should I be getting an extra booster with the new type of vaccine?

French health authorities launched the autumn booster campaign on October 3rd includes newly authorised dual-strain vaccines – such as the Pfizer/BioNTech vaccine adapted to BA.1, the Moderna vaccine adapted to BA.1, and the Pfizer/BioNTech vaccine adapted to BA.4/5 – which are designed to combat the Omicron variant.

It will be followed by the seasonal flu vaccination campaign in mid October.

READ MORE: When, where and how to get flu shots and Covid boosters this autumn in France

In France, about 6.3 million people have received a second booster dose, “or 41 percent of the eligible population,” said the Directorate General of Health (DGS) to Ouest France.

Currently only those in high risk groups are eligible for a second booster shot, including pregnant women, the elderly those with medical conditions or carers – find the full list here.

As almost half of the eligible population have already received a fourth vaccine, many are wondering whether they will be eligible for a fifth (or third booster) in order to access the new dual-strain vaccine.  

According to Virginie, a representative from HAS – France’s health authority – the organisation “no longer thinks in terms of doses for high-risk people and immunocompromised patients.”

Specifically, the HAS recommends that a new injection be given – and if possible one of the dual-strain vaccines – “regardless of the number of injections received up to now”.

READ MORE: EXPLAINED: Who qualifies for a second Covid vaccine booster in France?

However, French health authorities specified that the additional booster should “respect the minimum recommended time between two doses.”

“This depends based on your profile – for people aged 80 and over, residents of nursing homes or long-term care units (USLD) and those who are immunocompromised, the wait-time is three months between jabs. For the others, the delay is set at six months.”

For those who have already been infected by Covid-19, the HAS recommends that if you are eligible for a second (or third booster) that the additional dose “is still recommended, with a minimum delay of three months after infection.”

SHOW COMMENTS